Postpartum Analgesia in New Mothers (PAIN) Study: A Survey of Canadian Obstetricians’ Post-Delivery Opioid-Prescribing Practices

Autor: Natalie Dayan, Sophie Gosselin, Christine M. Gunn, Miriam Harris, Tanya Girard, Cristina Longo, Amira El-Messidi, Erica Marrone, Emily G. McDonald, Gabriel D. Shapiro
Rok vydání: 2021
Předmět:
Zdroj: J Obstet Gynaecol Can
ISSN: 1701-2163
DOI: 10.1016/j.jogc.2020.11.018
Popis: Objective We aimed to describe opioid prescribing practices after obstetric delivery and to evaluate how these practices compare with national opioid prescribing guidelines. Methods A closed survey was developed, evaluated for validity and reliability, and distributed by email to obstetrician members of the Society of Obstetricians and Gynaecologists of Canada (SOGC) in December 2018. Descriptive statistics were used to summarize respondent demographics, pharmaceutical pain management strategies, and opioid prescribing practices. Logistic regression was used to measure associations between respondent characteristics and high-risk opioid prescribing practices (e.g., prescribing >50 mg morphine equivalent dose per day, prescribing >5 days, not screening for substance/opioid use disorder before prescribing). Results Our survey had high content validity (content validity index 0.89; 95% CI 0.78–1.00) and adequate reliability (Kappa 0.70; 95% CI 0.63–0.84 and intraclass correlation coefficient 0.70; 95% CI 0.67–0.81). Of the 1019 SOGC members reached, 243 initiated the survey (response rate, 24%). Among respondents, 235 (92%) completed the survey. Among opioid prescribers, 47% reported at least 1 high-risk opioid prescribing practice, the most frequent being a lack of substance/opioid use disorder screening. In the adjusted logistic regression model, being in practice more than 20 years (adjusted odds ratio [aOR] 0.53; 95% CI 0.29–0.93) and practising in a non-central area of Canada (aOR 0.49; 95% CI 0.28–0.84) reduced the odds of high-risk prescribing. Conclusion Further research on barriers to screening are needed to support and enhance safer opioid prescribing practices among Canadian obstetricians.
Databáze: OpenAIRE